tradingkey.logo
tradingkey.logo
Search

Eledon Pharmaceuticals Inc

ELDN
Add to Watchlist
3.380USD
-0.030-0.88%
Close 07-31 16:00ETQuotes delayed by 15 min
260.89MMarket Cap
LossP/E TTM

ELDN Financials

See Eledon Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Eledon Pharmaceuticals Inc Earnings Date

Latest Release
May 13, 2026
EPS / Forecast
-0.35/-0.18
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-0.56
25.22%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-312.21%-0.35
-130.55%-0.11
32.85%-0.23
86.31%-0.15
89.31%-0.08
135.58%0.36
-1.96%-0.34
61.22%-1.06
-4.50%-0.79
75.51%-1.00
---0.33
---2.74
---0.75
---4.09
----
----
----
----
----
----
Net Profit
-500.85%-39.02M
74.97%-10.45M
-132.08%-17.46M
75.02%-11.22M
72.51%-6.50M
-38.66%-41.73M
649.45%54.43M
31.71%-44.91M
-119.37%-23.63M
48.45%-30.10M
5.40%-9.91M
-611.15%-65.76M
-9.21%-10.77M
-563.00%-58.38M
-6.66%-10.47M
-25.23%-9.25M
-16.06%-9.86M
-49.15%-8.81M
-59.78%-9.82M
-185.54%-7.38M
Debt to assets ratio
----
----
----
----
----
----
----
----
----
----
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
----
----
Operating profit
-17.91%-21.18M
13.01%-21.48M
7.02%-19.07M
-70.55%-24.73M
-65.28%-17.96M
-138.89%-24.70M
-83.16%-20.51M
-40.06%-14.50M
2.17%-10.87M
-2.97%-10.34M
-5.66%-11.20M
-11.54%-10.35M
-12.69%-11.11M
-6.98%-10.04M
-0.88%-10.60M
-16.46%-9.28M
-9.48%-9.86M
-47.61%-9.38M
-141.74%-10.51M
-279.39%-7.97M
Net Profit
-500.85%-39.02M
74.97%-10.45M
-132.08%-17.46M
75.02%-11.22M
72.51%-6.50M
-38.66%-41.73M
649.45%54.43M
31.71%-44.91M
-119.37%-23.63M
48.45%-30.10M
5.40%-9.91M
-611.15%-65.76M
-9.21%-10.77M
-563.00%-58.38M
-6.66%-10.47M
-25.23%-9.25M
-16.06%-9.86M
-49.15%-8.81M
-59.78%-9.82M
-185.54%-7.38M
Current assets
-11.07%113.57M
-5.60%135.69M
18.15%96.30M
27.73%111.40M
166.21%127.72M
156.07%143.73M
29.40%81.51M
18.47%87.22M
-1.90%47.98M
-5.69%56.13M
-6.77%62.99M
1.15%73.62M
-38.35%48.90M
-32.63%59.52M
-29.29%67.56M
-29.04%72.79M
-28.04%79.33M
-23.60%88.35M
-16.98%95.56M
950.94%102.58M
Total current liabilities
46.52%13.46M
58.45%18.34M
14.47%14.30M
127.70%13.72M
116.27%9.19M
197.23%11.58M
330.80%12.49M
22.96%6.03M
-22.47%4.25M
-39.85%3.90M
-53.84%2.90M
49.57%4.90M
85.19%5.48M
47.13%6.47M
55.22%6.28M
22.38%3.28M
-29.67%2.96M
77.25%4.40M
-34.00%4.05M
144.03%2.68M
Total assets
-9.08%146.67M
-4.73%169.01M
13.34%129.86M
20.27%144.91M
99.59%161.31M
99.18%177.41M
19.26%114.58M
12.83%120.48M
-1.81%80.82M
-4.02%89.07M
-35.78%96.07M
-30.98%106.78M
-49.00%82.31M
-45.59%92.79M
-15.57%149.59M
-16.06%154.71M
-15.81%161.38M
-13.51%170.55M
-8.00%177.17M
1655.12%184.31M
Total liabilities
-1.11%46.21M
-45.62%32.23M
0.74%38.80M
-69.86%38.88M
-51.09%46.73M
949.50%59.27M
713.65%38.52M
1786.83%128.98M
1171.57%95.55M
-34.41%5.65M
-44.26%4.73M
28.33%6.84M
48.50%7.51M
31.39%8.61M
32.25%8.49M
-7.90%5.33M
-35.22%5.06M
-0.55%6.55M
-96.25%6.42M
405.15%5.78M
Total equity
-12.33%100.46M
15.78%136.78M
19.72%91.05M
1347.24%106.03M
877.97%114.58M
41.62%118.14M
-16.73%76.06M
-108.51%-8.50M
-119.69%-14.73M
-0.91%83.42M
-35.27%91.33M
-33.09%99.95M
-52.15%74.79M
-48.67%84.18M
-17.37%141.09M
-16.32%149.38M
-14.98%156.32M
-13.96%164.00M
693.96%170.75M
1808.09%178.52M
Net operating income
-40.80%-22.61M
25.79%-14.09M
-23.01%-14.48M
-127.85%-17.71M
-83.73%-16.06M
-107.94%-18.99M
3.93%-11.77M
5.44%-7.77M
11.92%-8.74M
3.68%-9.13M
-168.02%-12.25M
-32.23%-8.22M
-21.68%-9.92M
-2.95%-9.48M
35.56%-4.57M
16.51%-6.22M
-57.88%-8.16M
2.39%-9.21M
-1164.35%-7.09M
-146.47%-7.45M
Net investment
53.03%5.96M
56.81%-20.46M
196.90%12.40M
175.12%14.96M
-60.22%3.89M
-570.25%-47.38M
48.85%-12.80M
34.35%-19.91M
--9.78M
--10.08M
---25.03M
---30.33M
----
----
----
----
----
--0.00
-100.00%0.00
----
Net financing
-100.00%0.00
-33.02%53.69M
-100.00%0.00
-100.00%0.00
11400.00%115.00K
--80.17M
--5.28M
45.59%48.07M
--1.00K
--0.00
--0.00
--33.02M
----
--0.00
-100.00%0.00
--0.00
100.00%0.00
-100.00%0.00
-100.00%1.00K
--0.00

FAQs

What are the current assets of Eledon Pharmaceuticals Inc?

According to Eledon Pharmaceuticals Inc's FY2025 earnings report, its current assets were 135.69M, with a year-on-year change of -5.60.

What are the total assets of Eledon Pharmaceuticals Inc?

According to Eledon Pharmaceuticals Inc's FY2025 earnings report, its total assets of Eledon Pharmaceuticals Inc were 169.01M, with a year-on-year change of -4.73.

What are the total liabilities of Eledon Pharmaceuticals Inc?

According to Eledon Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Eledon Pharmaceuticals Inc were 32.23M, with a year-on-year change of -45.62.

What is the total equity of Eledon Pharmaceuticals Inc?

According to Eledon Pharmaceuticals Inc's FY2025 earnings report, its total equity of Eledon Pharmaceuticals Inc was 136.78M, with a year-on-year change of 15.78.

What is the net operating income of Eledon Pharmaceuticals Inc?

According to Eledon Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Eledon Pharmaceuticals Inc was -83.25M, with a year-on-year change of -17.96.

What is the net investment of Eledon Pharmaceuticals Inc?

According to Eledon Pharmaceuticals Inc's FY2025 earnings report, its net investment of Eledon Pharmaceuticals Inc was 10.79M, with a year-on-year change of 115.35.

What is the net financing of Eledon Pharmaceuticals Inc?

According to Eledon Pharmaceuticals Inc's FY2025 earnings report, its net financing of Eledon Pharmaceuticals Inc was 53.81M, with a year-on-year change of -59.70.

What is the Earnings Per Share (EPS) of Eledon Pharmaceuticals Inc?

According to Eledon Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.56, with a year-on-year change of 25.22.

What is the net income of Eledon Pharmaceuticals Inc?

According to Eledon Pharmaceuticals Inc's FY2025 earnings report, its net income was -45.62M, with a year-on-year change of -26.07.

What is the Return on Equity (ROE) of Eledon Pharmaceuticals Inc?

According to Eledon Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -45.79, with a year-on-year change of -27.55.

What is the Return on Assets (ROA) of Eledon Pharmaceuticals Inc?

According to Eledon Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -26.34, with a year-on-year change of 3.02.

What is the operating profit of Eledon Pharmaceuticals Inc?

According to Eledon Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -83.25M, with a year-on-year change of -17.96.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.